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Abstract: Mesenchymal stem cells (MSCs) reside quiescently within a specialised ‘niche’ environment
in the bone marrow. However, following appropriate signalling cues, MSCs mobilise and migrate out
from the niche, typically toward either sites of injury (a regenerative response) or toward primary
tumours (an intrinsic homing response, which promotes MSCs as cellular vectors for therapeutic
delivery). To date, very little is known about MSC mobilisation. By adopting a 3D MSC niche model,
whereby MSC spheroids are cultured within a type I collagen gel, recent studies have highlighted
interleukin-6 (IL-6) as a key cytokine involved in MSC migration. Herein, the ability of IL-6 to induce
MSC migration was further investigated, and the key matrix metalloproteinases used to effect cell
mobilisation were identified. Briefly, the impact of IL-6 on the MSC migration in a two-dimensional
model systems was characterised—both visually using an Ibidi chemotaxis plate array (assessing for
directional migration) and then via a standard 2D monolayer experiment, where cultured cells were
challenged with IL-6 and extracted media tested using an Abcam Human MMP membrane antibody
array. The 2D assay displayed a strong migratory response toward IL-6 and analysis of the membrane
arrays data showed significant increases of several key MMPs. Both data sets indicated that IL-6 is
important in MSC mobilisation and migration. We also investigated the impact of IL-6 induction on
MSCs in 3D spheroid culture, serving as a simplistic model of the bone marrow niche, characterised
by fluorescently tagged magnetic nanoparticles and identical membrane antibody arrays. An increase
in MMP levels secreted by cells treated with 1 ng/mL IL-6 versus control conditions was noted in
addition to migration of cells away from the central spheroid mass.
Keywords: magnetic nanoparticles; matrix metalloprotease; tissue inhibitor of metalloprotease;
mesenchymal stem cell; type I collagen; spheroid
1. Introduction
Stem-cell-based therapies have the potential of becoming the future of medicine [1], personalised
to the patient [2]. Embryonic stem cells (ESCs) have the highest differentiation potential, offering
limitless possibilities for tissue replacement. However, sourcing embryonic stem cells poses ethical
concerns, and current UK regulations restrict their availability to the first 14 days, so a more plentiful
source of stem cells would be necessary for wide-scale uptake of stem cell therapy. Therefore, the more
readily available adult stem cell populations, such as mesenchymal stem cells (MSCs), are of great
interest when new therapies and technologies are developed [3].
MSCs derived from the bone marrow niche are multipotent, capable of differentiating into
osteoblasts (bone), chondroblasts (cartilage), and adipoblasts (fat) [4]. These precursor cells are essential
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to the formation, maintenance, and repair of the skeleton. MSCs are identified by several cell surface
markers including the presence of CD105, CD90, and CD73 and the absence of CD45, CD34, CD14,
CD19, and HLA-DR [5]. MSCs grown in monolayer will typically begin to lose differentiation potential
from around the 6th passage, demonstrating the vital role cell signalling from other supporting cell
types within the bone marrow microenvironment plays in maintaining stemness [6,7]. Within the bone
marrow microenvironment, the MSC niche can be subdivided into the endosteal and the perivascular
niches, where MSC populations are maintained by, and communicate via cytokines, with other
cells, such as hematopoietic stem cells (HSCs) and later precursor cells such as osteoblasts and
adipoblasts [8–10].
Upon appropriate signalling cues, MSCs mobilise and migrate out from the niche [11].
MSC mobilisation is often due to either (1) homing to sites of injury [12,13] or (2) homing to
disseminated tumour cells [14]—both are of key interest to researchers in terms of regenerative
medicine (i.e., replacement of lost skeletal tissue) and potential therapeutics for cancer. To date the
precise mechanism of mobilisation remains poorly understood.
To gain a deeper understanding of MSC behaviour within the bone marrow microenvironment,
it is important to develop more accurate in vitro model systems. One key approach to bring this to
fruition is the development of three-dimensional (3D) cell culture model systems. Unlike standard
two-dimensional (2D) monolayer cultures, 3D models display nutrient and oxygen gradients,
providing a more physiological representation. In addition to this, a more in vivo-like cell behaviour is
encouraged, leading to longer culture life spans offering a useful platform for more accurate assessment
of drug efficacy during cell cytotoxicity tests [15–17].
The 3D culture adopted in this study utilises MSC internalisation of magnetic nanoparticles
(mNPs), prior to levitation in response to an external magnetic field (280 mT), which coerces
magnetically labelled MSCs together to form cell aggregates or spheroids. It has been confirmed
in multiple studies [18–20] that mNPs do not adversely affect cells and their presence allows cell
imaging to be done quickly, without fixation and subsequent staining, as the mNPs are conjugated
to, in this case, fluorescein molecules. The spheroids are then cultured within type 1 collagen gels
(Figure 1), where MSC spheroids display stem cell-like properties, with cells entering a quiescent
state, maintaining a population of multipotent cells capable of responding to modelled wound sites by
migration and differentiation [18].
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i re 1. Schematic of three-dimensional spheroid culture. Following its formation, t e spheroid is
levitated in a type I collagen gel where it can be maintained for several weeks.
Injury or inflammation cause cellular release of cytokines, transforming growth factor-ß (TGF-ß),
tumour necrosis factor-α (TNF-α), several interleukins (IL) such as IL-1, IL-6, and IL-10, and the
interferons, which all play an important role in controlling the immune response [21]. These cytokines
also stimulate the recruitment of MSCs where they initiate tissue repair at the site of the wound [22].
Previously published work fr our lab assessed migratory signals produced by artificial wound
models [12]. From a panel of everal key cytokin s (IL-1b, Il-2, TNFα, IL-12p70, and IL-6), only IL-6
was identified as being able to induce MSC igration fr m the spheroid odels [12]. Well known
for its roles within inflammation, immune response, and skeletal maintenance, IL-6 is also a key
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regulator in cell differentiation, as it is heavily associated with haematopoiesis and differentiation of
both osteoblasts and osteoclasts [23–26].
Understanding MSC migration will help inform on potential delivery routes in cancer therapeutics
and within the field of regenerative medicine. Cell migration involves the breakdown of extracellular
matrix (ECM), which requires the action of proteolytic enzymes such as matrix metalloproteinases
(MMPs). There are several classes of MMPs depending on their substrate specificity: (1) collagenases
(MP-1, -8, -13, and -18), which cleave fibrillar collagens type I, II, and III, (2) gelatinases (MMP-2
and -9), which cleave gelatin, but can also degrade other extracelluar matrix proteins including
collagen and laminin, (3) stromelysins (MMP-3, -10, and -11), which degrade several non-collagenous
proteins, and (4) membrane-type MMPs (MMP-14, -15, -16, -17, -24, and -25) [27,28]. MMP activity is
regulated by tissue-specific inhibitors of MMPs (TIMPs). The balance between MMPs and TIMPs is
critical in ECM remodelling, cell migration, cell differentiation, and the regeneration of any tissue [29].
Therefore, the involvement of these enzymes in MSC migration could provide valuable information
with regard to tissue regeneration. In this study, we aim to identify which MMPs are employed in
IL-6-induced migration in both 2D and 3D MSC culture by analysing media extracted from monolayer
and spheroid cultures. The presence of a panel of seven human matrix metalloproteinases (MMP-1,
MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, and MMP-13) was quantified following IL-6 addition
into the microenvironment. A panel of three tissue inhibitors of metalloproteinases (TIMPs; TIMP-1,
TIMP-2, and TIMP-4) was also assessed, to analyse the relationship between protein and inhibitor
following IL-6 sensing by cells. TIMPs directly inhibit MMP protein via binding of the active site [30].
To complement this analysis, monolayer cells were also observed on an Ibidi cell migration plate assay
(using time lapse microscopy) over a 24 h period in the presence of IL-6, whilst spheroids were imaged
over a series of days both in the presence and absence of IL-6, allowing visualisation of both 2D and
3D migratory response leading to a greater understanding of the migration and giving further insight
into the role IL-6 plays within these model systems.
2. Materials and Methods
2.1. Expansion Cell Culture
Human Mesenchymal Stem Cells (Promocell) were cultured using modified DMEM made up of
400 mL of Dulbecco’s modified Eagle’s medium, 100 mL of media 199, 50 mL of foetal bovine solution,
10 mL of penicillin-streptomycin, and 5 mL of sodium pyruvate. When maintained in culture flasks of
MSC cultures were passaged using standard established procedures when confluent and the media
refreshed every 3–4 days.
2.2. µ-Slide Chemotaxis 2D
The kit provided by Ibidi allows the measurement of directional movement of a group of cells
in response to a chemoattractant. Using the set protocol provided with the ‘3D Chemotaxis Assay
Using µ-Slide Chemotaxis—2.2 2D Chemotaxis Experiments without Gel’ slides, MSCs were seeded at
1 × 105. Once both reservoirs were filled with 60 µL of chemoattractant-free DMEM, 30 µL of 1 ng/mL
IL-6 was aspirated into the left reservoir to begin the chemoattraction for the assay. The plate was then
imaged on a 4× objective lens at 120 s intervals over 24 h at 37 ◦C. Results were then analysed using
the ImageJ plugin ‘manual tracking’ and Ibidi’s own ‘Chemotaxis and Migration’ tool.
2.3. Preparation of Array Membrane Samples
MSCs were seeded at 5 × 104 in 1 mL of media in a 24-well plate and incubated for 24 h (37 ◦C
and 5% CO2). Cellular migration was then induced by adding 1 mL of 1 ng/mL IL-6, and cells were
incubated for two set time periods—3 h and 24 h. After each set incubation period media was extracted
and stored at −20 ◦C prior to use on Abcam MMP Antibody Array Membranes.
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2.4. Generation of Three-Dimensional Spheroid Model System
Spheroids were generated using the methodology as described in Lewis et al. (2016) [12]. Cells
were initially seeded at a density of 1 × 104 into a 24-well plate and cultured for 24 h (37 ◦C; 5% CO2).
After this initial incubation, each well of cells was incubated with 0.1 mg/mL suspension of green
fluorescently labelled magnetic iron oxide nanoparticles (chemicell—fluidMAG-PEA with a magnetite
core; iron oxide, Fe3O4) in 1 mL of DMEM for 30 min (37 ◦C; 5% CO2) above a 24-well 280 mT magnetic
array plate (Chemicell). After the 30 min incubation, the media was removed and excess iron washed
from each well using HEPES saline. Cells were then detached from the surface using trypsin and
resuspended in 4 mL of fresh media in a 6-well plate; a magnet 10 mm in diameter (280 mT) was
placed on the top of each well, and MSCs were further cultured for 24 h to allow spheroid formation.
Once formed, the spheroids were carefully transferred into a type I collagen gel and cultured in 1 mL
of fresh media.
2.5. Collagen Gel Preparation
Collagen gels for maintaining and culturing spheroids was made up by initially premixing 0.5 mL
of foetal bovine solution, 0.5 mL of modified DMEM culture media, and 0.5 mL of alpha-MEM making
up an initial premix of media. Exactly 2.5 mL of rat tail collagen was mixed with 1 mL of 0.1 M NaOH,
before mixing with the media premix. Additional NaOH was then titrated dropwise until entire
solution turns from yellow/orange to a stable pink, indicating the correct pH change required for
gelation. One milliliter of the gel solution was added to individual spheroids within a 24-well plate.
A setting period of ≤1 h at 37 ◦C was permitted prior to the addition of fresh culture media.
2.6. Electron Microscopy Preparation
Cell spheroids were generated before fixing in 2.5% glutaraldehyde/0.1 M phosphate buffer
fixative for 1 h at room temperature before rinsing in buffer three times for 5 min. Fixed spheroids
were treated in osmium tetroxide/0.1 M phosphate buffer for 1 h and washed with distilled water
three times for 10 min before being treated in uranyl acetate for 1 h in the dark. Spheroids were then
dehydrated in increasing (ethanol) for 10 min until absolute ethanol. Scanning EM samples were then
dried in hexamethyldisilazane before they were mounted on SEM stubs. Mounted samples were then
coated with 10 nm gold/palladium using a polaron SCS15 SEM coating system. Samples were viewed
using JOEL 6400 SEM at 10 kV. Images were false coloured with Adobe Photoshop CS4.
Tunnelling EM sample spheroids were further processed by first washing in propylene oxide three
times for 5 min then a 1:1 mix of propylene oxide: araldite/epon 812 resin overnight. These samples
were then embedded in fresh araldite resin and set in moulds for 48 h to allow the resin to polymerise.
Seventy-nanometer sections were cut using a Leica Ultracut UCT and a Diatome diamond knife at
an angle of 6◦. Sections were then mounted on 100 mesh formvar-coated copper grids and then
contrast-stained with 2% methanolic uranyl acetate for 5 min and with Reynold’s lead citrate for a
further 5 min before imaging on JOEL 1200 TEM at accelerating velocity of 80 kV.
2.7. Inducing Migration and Preparation of Samples
MSC spheroids were either cultured with DMEM alone as control samples or induced using
1 ng/mL IL-6. Media samples of induced spheroids were extracted and stored at −20 ◦C on Days 1
and 3 in preparation for use on Abcam MMP Antibody Array membranes. To better understand the
cell migratory processes within a 3D cellular spheroid system, spheroids of both IL-6-induced and
media-only control samples were also imaged at Days 0, 1, and 3 for qualitative exploration of cellular
migration from spheroids using Zeiss Axio Vert A1 flourescence microscope (excitation at 365 nm and
emission at 420 nm to detect fluorescein conjugated to mNPs).
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2.8. Abcam Human MMP Antibody Array Membranes
Following the protocol in the Human MMP Antibody—Array Membrane ‘Instructions for use’
booklet media, samples from (i) the 2D MSC IL-6 Induced Samples at 3 and 12 h and (ii) the 3D MSC IL-6
induced samples at Days 1 and 3 were incubated overnight on array membranes at 4 ◦C. The following
day, media samples were aspirated off, and membranes were washed using the supplied buffers
and incubated for 2 h at room temperature in 1 mL of biotin-conjugated anti-cytokines. Membranes
were then rewashed and incubated in 2 mL of HRP-conjugated streptavidin overnight at 4 ◦C. Prior
to chemiluminescence detection, streptavidin was removed, and membranes were washed a final
time. Membranes were then transferred, printed side up, onto provided plastic sheets and detection
buffers pipetted onto each sample. After 2 min of incubation, a second plastic sheet was placed on
top and membranes were imaged via chemiluminescence detection using a CCD camera with 20 s
exposure times.
3. Results and Discussion
MSCs, in a 2D culture, were initially observed to migrate toward an IL-6 gradient in response to
IL-6, at a concentration previously noted to induce MSC migration from 3D spheroids (350 pg/mL; [12]).
Upon IL-6 exposure, cells were tracked over 24 h using time-lapse light microscopy. A clear
directionality was observed toward the IL-6-spiked DMEM, where large filopodia were noted
extending in the direction of IL-6, inducing a leading edge and migration (Figure 2) [31]. Cell migration
was analysed to assess global migration over 24 h; a rose plot confirmed MSC preferential migration
toward IL-6 (positive axis; Figure 3B). A vector plot further supported the motility of each analysed cell
from the point of origin (Figure 3A). Thus, MSCs preferentially moved >50 µm toward [IL-6] within
the 24 h period.
Cytokines are secreted, principally, by lymphocytes and macrophages. They act by altering the
function of target cells in a paracrine or autocrine fashion. However, invading breast cancer cells,
within the bone marrow, have been noted to secrete cytokines initiating an epithelial-to-mesenchymal
transition leading to a metastatic phenotype. This signalling occurs at very low concentrations
(pg/mL–ng/mL) [32]. MSCs are known to respond to TNFα, IFNγ, IL-1, and IL-6 concentration
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Figure 2. A montage of six images taken from the 24 h time-lapse following a single MSC cultured
within an Ibidi µ-Slide Chemotaxis 2D assay plate with IL-6/DMEM (1 ng/mL) in the first reservoir
and culture media alone in the reservoir on the right.
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Changes  in  MMP/TIMP  levels  were  quantified  and  expressed  graphically  (Figure  4).  MMP 
transcription  is  regulated  by  cytokines  [35];  hence,  as  the  cell  is  exposed  to  IL‐6,  secretion  of 









Figure 3. Analysis of images generated during the 24 h S ti e-lapse imaging using the manual
tracking plugin for ImageJ and the chemotaxis tool provided by Ibidi. IL-6 containing media was
situated toward the positive axis. (A) Vector plot based on the tracking of 8 randomly selected cells
showing the vector each cell has moved from origin with (B) showing the directionality of the cells as a
rose plot.
3.1. MMP-1 and MMP-3 Facilitate MSC IL-6-Induced Migration in Monolayer
MSCs were incubated in IL-6 (1 ng/mL); culture media was then collected after 3 h and
24 h and analysed for the presence of matrix metalloproteases (MMPs) and their tissue inhibitors
(TIMPs). Changes in MMP/TIMP levels were quantified and expressed graphically (Figure 4).
MMP transcription is regulated by cytokines [35]; h nce, as the c ll is xposed to IL-6, secretion
of collagen ses MMP-1 and MMP-3 is upregulated. Secretion f the corresponding inhibitor [34],
TIMP-1, lso rises as a bala ce s ought to prevent pathological condi ions [36]. In this way, IL-6 will
facilitate cell migration until i is exhausted. An increase in the MSC rate of migration has previously
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Figure 4. Mean pixel density of target proteins secreted into culture media by IL-6-induced MSCs at
3 h (black) and 24 h (grey) hour intervals. lt r i as analysed using Abcam human MP
antibody arr y me branes, viewed on Agilent 210 i er, fo lowed by quant fication using
ImageJ. Values analysed via t-test, * p < 0.0 5.
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3.2. Magnetic Nanoparticles Enable MSC Spheroid Culture
The effect of MSC cell seeding density with regard to resultant spheroid size was assessed
(Figure 5). Three different seeding densities were used; 6 × 103, 1 × 104, and 2 × 104 cells/mL, with
spheroid diameter measured after 24 h in culture medium under 280 mT magnetic field, based on the
green fluorescent magnetic nanoparticles within the cells. There was no significant difference (p > 0.005)
in the mean areas of spheroids (Figure 5D); however, interestingly, spheroid number increased with
seeding density, suggesting that the cells have a finite rate of spheroid formation within 24 h. Further
characterisation via scanning electron microscopy indicates the close relationship between cells within
the spheroid. MSCs become compacted when compared with the monolayer culture, where cell
diameter is >50 µm, but here MSCs do not exceed 10 µm and are tightly bound to neighbouring cells
(Figure 5E). Tunnelling electron microscopy allows the internal structures of the MSC to be probed.
Once internalised, mNPs are retained inside endosomes within the cell cytoplasm (Figure 5F), but do
not enter the nucleus and are not toxic to the cell (as shown in previous publications [12,18,38]).
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Scale bar = 10 µm. (D) Box and whisker plot of spheroid areas (spheroid n ≥ 15). (E) False colour
scanning electron microscopy of MSC spheroid using JEOL JSM-6400 scanning electron microscope
at 10 kV. (F) Tunnelling electron microscopy of MSC spheroid using JEOL 1200 tunnelling electron
microscope at 80 kV; scale bar = 1 µm. Cells labelled with green fluorescent mNPs were levitated in
magnetic field for 24 h before measurement. Diameter measured using ImageJ.
3.3. MSCs Migrate in Response to IL-6 in Three-Dimensional Spheroid Culture
Following observations that MSCs migrated in response to an IL-6 gradient in 2D culture, MSC
spheroids were observed for cell migration in response to IL-6 over a 3-day period. MSCs were
developed into three-dimensional spheroids and levitated in collagen gels, using mNPs, to produce an
in vitro culture model the bone marrow microenvironment [12,38]. As noted in Figure 6, following
IL-6 exposure, initial MSC migration was observed after 3 h, with very apparent cell migration after
24 h IL-6 exposure.
In vivo, cells would migrate toward the source of IL-6 [39], in the case of this in vitro experiment,
there is no singular source of IL-6 (such as co-cultured cells) and concentration is uniform across
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the whole culture. MSCs will, therefore, migrate out of the central mass in all directions. Indeed,
fluorescent images of these spheroids indicate a migration of cells from the central mass following
IL-6 treatment compared with a retention of spheroid shape in the control culture, not treated with
the cytokine (Figure 6). Cells within the spheroid therefore appear to sense IL-6, most likely via the
cognate cell surface receptor, IL6R [21], and the peripheral cells will transition from adherent cells to a
migratory cell phenotype, to move toward the source of IL-6. This was observed in spheroids treated
with IL-6, where peripheral cells increase in size as they change morphology to facilitate migration
(Figure 6D). It should be noted that MSC spheroids may react to the presence of other MSC spheroids
in their vicinity within the collagen gel, so even in control conditions cells may begin to migrate from
the mass, but the effect of IL-6 on the migration of MSCs is much more pronounced.
Appl. Sci. 2018, 8, x FOR PEER REVIEW    8 of 12 
directions.  Indeed,  fluorescent  images  of  these  spheroids  indicate  a migration  of  cells  from  the 
central mass following IL‐6 treatment compared with a retention of spheroid shape  in the control 
culture, not treated with the cytokine (Figure 6). Cells within the spheroid therefore appear to sense 

















TIMP  secretion  from  1  to  3  days  (Figure  7).  This  correlates with  previous  evidence  that MSCs 
become  quiescent  in  collagen  gels with  time  and  thus do not migrate  [18]. However,  the MMP 
secretion profile  for MSC  spheroids challenged with 1 ng/mL  IL‐6  is notably different;  there  is a 
significant  increase  in  MMP‐8  a  collagenase  specific  to  types  I‐III  [30].  Interestingly,  other 
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Figure 6. MSC spheroids (10,000 cells/mL) cultured in (A) standard media at 3 h; (B) 1 ng/mL IL-6 at
3 h; (C) standard media at 24 h; (D) 1 ng/mL IL-6 at 24 h. Arrows indicate initial cellular migration at
3 h. Green indicates presence of mNPs. Images taken with Zeiss Axio Vert A1 fluorescent microscope
(excitation = 365 nm and emission = 420 nm). Scale bar = 10 µm.
3.4. MMP-2 and MMP-8 Facilitate MSC IL-6-Induced Migration in 3D Spheroid Culture
In order for MSCs to migrate, they must change from an adhesive phenotype to a migratory
phenotype. The migratory behaviour of MSCS involves MMP activity, with different MMP profiles
depending on the migratory reaso [29]. Within our system, focusing on MSC migration in response
to IL-6, MSC spheroids cultured in standa d DMEM indicated an overall decr ase i both M P and
TIMP secretion from 1 to 3 days (Figure 7). This correlates with previous evidence that MSCs become
quies ent i collagen gels with time and thus do not migrate [18]. However, the MMP secretion profile
for MSC spheroids challenged with 1 ng/mL IL-6 is notably different; there is a significant increase in
MMP-8 a collagenase specific to types I-III [30]. Interestingly, other collagenases specific to collagen
type I, MMP-1 and MMP-13, show no significant change following IL-6 treatment. The only significant
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change in TIMP secretion was through an increase in TIMP-4. TIMP-4 is known to interact with
MMP-2 [40], a gelatinase, which indicates a significant decrease following IL-6 treatment (Figure 7).
The MMP profiles seen in 2D and 3D differ notably in the types of MMP upregulated and the levels with
which they change. In monolayer culture, MSCs are only surrounded by ECM laid down themselves
and any proteins that may be present in the foetal calf serum within the culture medium. However, in
3D culture, cells are surrounded by type I collagen, making migration much more difficult and thus
taxing on the cell, hence why the secretion of some MMPs are downregulated.
MSCs respond to IL-6 in their environment, often secreted by invading cancer cells. IL-6 activates
JAK/STAT and MAPK pathways to permit survival and proliferation of MSCs [41]. This leads to the
formation of actin stress fibres to facilitate migration [42]. In this way, local MSCs act as a source of
fibroblasts to permit tumourigenesis of the neoplastic cells [43]. Therefore, the response of MSCs to
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toward  IL‐6  in  both  2D  and  3D  cultures,  but  also  that,  based  on  a  comparison  of  both  culture 
Figure 7. MSC spheroid MMP and TIMP secretion into culture medium at 3 h (black) and 72 h (grey).
(A) Standard media and (B) DMEM with 1 ng/mL IL-6. Protein array membranes viewed using Agilent
2100 Bioanalyser, followed by quantification using ImageJ. Values analysed via t-test, * p < 0.005.
4. Conclusions
We aimed to use a 3D spheroid cult re sy tem to det rmine whether MSCs migrate toward an IL-6
signal and, if so, what changes in MMP/TI P secretion pr files facilitate such migration. Cells in vivo
will rarely expe ience conditions such as those of a monolayer culture, as cells in vi o grow in a
complex 3D environment. Magnetic nanoparticles facilitated spheroid generation and llowed for the
tracking and imaging of MSCs during culture. Our results show not only that MSCs migrate toward
IL-6 in both 2D and 3D cultures, but also that, based on a comparison of both culture systems, the
secreted MMP profiles change. In a 2D culture, MMP-1 and MMP-3 are secreted during migration,
whereas MMP-8 is increased in a 3D spheroid/collagen gel culture. The adoption of a magnetic MSC
Appl. Sci. 2018, 8, 412 10 of 12
spheroid culture therefore provides a simple and effective approach for studying MSC migratory
behaviour within a 3D environment; additional studies on other key cytokines would further our
knowledge base with regard to MSC migration during wound and tissue healing/regeneration.
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